Mikhail Blagosklonny is a respected professor of Oncology who is currently based at the Roswell Park Cancer Institute. The successful scientist focuses on cancer and aging in the school. Mikhail Blagosklonny has achieved a lot in his challenging career.
Mikhail Blagosklonny acquired his education from the prestigious Pavlov State Medical University. After obtaining his first degree, he chose to further his studies in the same institution. The scientist specialized in experimental medicine and cardiology, graduating with masters.
Mikhail Blagosklonny was appointed to serve at the popular Medical College in the year 2002. Mikhail was working at the institution’s New York City branch as an associate professor. The successful scientist worked in the firm for some years before joining Ordway Research Institute.
At Ordway, Mikhail served as a senior scientist. He was the leader of the research strategies in the company. Mikhail worked hard at the institution, fulfilling all his duties. The position enabled him to acquire a lot of expertise, and this has made him one of the most influential people in the oncology world. The scientist served in the company for several years. In 2009, the oncology expert was appointed to work as a lecturer at the well-known Roswell Park Cancer Institute. Mikhail works at the institution up to date, and he mostly focuses on cancer studies.
Mikhail has been able to do a lot of research on molecular and biology topics. People in the world respect him for his accomplishments in the medical field. The scientist is believed to have played a key role in the establishment of Cell Cycle, a popular journal that mostly covers medical topics such as cancer cell cycling and mitosis. Visit classroomvoices.org to read more about Mikhail.
In a recent interview, the scientist says that he is very passionate about research, especially on issues concerning age and cancer. Mikhail has concentrated his efforts in cancer therapies that he hopes can be useful in protecting the body cells from severe damages. In biogerontology, Mikhail has been able to produce effective anti-aging drugs. The scientist has also been working with Oncotarget as one of the senior editors. His publications in the journal have transformed the lives of many people in the world. Follow Mikhail on Google Scholar